PANTHERx® Rare, a leading provider of patient access and support services for rare disease therapies in the United States, has launched RxARECONCIERGE™, an innovative patient support model designed to streamline access, logistics, and coordination of care for individuals receiving cell and gene therapies (CGTs).
With the increasing adoption of CGTs, which require highly specialized support, PANTHERx developed RxARECONCIERGE™ to address the unique challenges associated with these groundbreaking treatments. The model provides:
- Comprehensive access and reimbursement support tailored to CGTs
- Ultra-low-temperature storage to maintain therapy integrity
- Just-in-time dispensing and fulfillment for seamless delivery to treatment centers
- Education and support for both patients and prescribing healthcare professionals (HCPs)
- Long-term tracking of patient-reported outcomes for continuous care improvements
- Actionable insights for CGT manufacturers to enhance treatment impact
“Since our founding in 2011, PANTHERx has excelled in helping patients and HCPs navigate the complexities of rare disease treatments, making the expansion to cell and gene therapies a natural progression,” said Bansi Nagji, PANTHERx Rare CEO. “Our RxARECONCIERGE™ model delivers truly coordinated care, offering a flexible, customized approach that aligns with the needs of patients, prescribers, treatment centers, insurers, and the manufacturers of cell and gene therapies.”
Also Read: AustinPx Launches KinetiSol™ Equipment Lease Program
A Tailored Approach to Cell and Gene Therapy Support
As CGTs revolutionize treatment for rare diseases, RxARECONCIERGE™ ensures that patients and providers receive specialized, end-to-end support throughout the treatment journey. The program simplifies the complex logistics, reimbursement, and adherence challenges that can delay or disrupt access to these advanced therapies.
By combining advanced distribution capabilities with dedicated patient and provider support, PANTHERx is setting a new standard for comprehensive rare disease care.